Business · 19/08/2025Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance on Assessing Overall Survival in Oncology Clinical Trials

The FDA has published a draft guidance for industry on assessing overall survival in oncology clinical trials, aiming to provide recommendations for sponsors on statistical and design considerations for analyzing overall survival as a prespecified safety endpoint.